je.st
news
Tag: chronic
'Chronic' underinvestment in North
2014-07-16 01:02:56| BBC News | Business | UK Edition
Lack of infrastructure investment in regional cities costs UK 5% lower growth a year, according to a report.
3D Systems Unveils 3D Printed Bespoke(TM) Braces for Chronic Condition Scoliosis
2014-06-09 06:00:00| Industrial Newsroom - All News for Today
"We typically think of design as design, and medicine as medicine, though in many cases, good design simply becomes good medicine" - designer Scott Summit.<br /> <br /> ROCK HILL, S.C. -- 3D Systems (NYSE:DDD) announced today that it has successfully completed a pilot program for its new Bespoke(TM) Braces, a first of its kind, personalized, 3D printed brace for children and young adults with scoliosis. In the Bespoke process, a prototype 'check-socket' brace is fitted to each patient, and, ...This story is related to the following:Surgical Braces
Tags: systems
condition
printed
chronic
Your dreams can be controlled by electrically stimulating your brain body hackers and chronic nightmare sufferers rejoice!
2014-05-12 14:53:33| Extremetech
It appears that applying an electrical current to your brain not only boosts your cognitive powers, but it can also help you obtain the mystical ability of lucid dreaming, where you can control the plot and outcome of your dreams. These findings come from a new study that found that lucid dreaming could be induced in a full 70% of participants, with a simple (external) electrical current passed across the frontal lobe. This has obvious applications for body hackers -- but perhaps more importantly it may have a medical use, too, in helping people who suffer from chronic nightmares.
Tags: body
controlled
dreams
brain
Glenmark's Novel Monoclonal Antibody GBR 900 For Treatment Of Chronic Pain Entering Human Trials
2014-04-30 07:12:40| drugdiscoveryonline News Articles
Glenmark Pharmaceuticals S.A., a wholly owned Swiss subsidiary of Glenmark Pharmaceuticals Ltd., announced today that GBR 900, a novel monoclonal antibody is entering human trials
Tags: human
treatment
pain
entering
Mercks Investigational Chronic Hepatitis C Combination Therapy MK-5172/MK-8742 Demonstrates Antiviral Activity in Hard-to-Cure Patients with HCV Genotype 1 Infection
2014-04-11 07:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Clinical Findings Support Initiation of C-EDGE Phase 3 Program WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced interim results from the ongoing C-WORTHy study, a multi-arm Phase 2 clinical trial evaluating the efficacy and safety of an all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor, among patients with chronic HCV Genotype 1 infection (GT1). Language: English Contact: MerckMedia Contacts:Caroline Lappetito, 267-305-7639Sarra Herzog, 201-669-6570orInvestor Contacts:Carol Ferguson, 908-500-1101Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: activity
combination
patients
therapy
Sites : [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] next »